Simple Predictor In Scleroderma Related Interstitial Lung Disease PDF Print E-mail
Tuesday, 23 October 2012 23:18
Patients at high risk of deterioration or death from Systemic Sclerosis-related interstitial lung disease can be readily spotted using CT scans, suggest Melbourne researchers.

Patients classified as having “extensive” (> 20%) lung disease as seen on an HRCT-lung  scan were three times more likely to die, need supplementary oxygen or a lung transplant, the authors wrote in Rheumatology.

Baseline HRCT-lung scans were available for 172 patients, who were followed for a mean of 3.5 years, with 30 experiencing an adverse outcome.

The level of lung disease identified on the scans was graded as ‘extensive’ (>20%), ‘limited’ (<20%) or ‘indeterminate’. Those classified as ‘indeterminate’ were allocated to either extensive or limited by looking at forced vital capacity, the authors said.

“I think it’s very important to have a HRCT-lung [scan] to confirm the diagnosis of interstitial lung disease in patients with Scleroderma,” author Dr Mandana Nikpour of the University of Melbourne and St Vincent’s Hospital Melbourne told Rheumatology Update.

“What we have confirmed is that there is an added value in that enables one to prognosticate as well.”

However Dr Nikpour did not recommend serial HRCT-lung scans because of the radiation exposure and cost and said that performing serial pulmonary function tests was a better way to track changes over time.

Saying that their grading system was “simple and quick” the authors proposed “the routine use of this HRCT grading system to obtain prognostic information in patients with SSc-ILD.”

Source: Pain, C (2012), "Simple predictor in systemic sclerosis-related ILD"; Rheumatology Update; Original article can be viewed here.

 
More articles :

» Pain Common in Systemic Sclerosis

Pain is common and can be severe in patients with systemic sclerosis, a cross-sectional analysis found.Among patients enrolled in the multicenter Canadian Scleroderma Research Group Registry, 83% experienced pain, more than one-third of them...

» Therapies for Scleroderma-related Pulmonary Arterial Hypertension

Paul M. HassounPosted: 08/20/2009; Expert Rev Resp Med. 2009;3(2):187-196. © 2009 Expert Reviews Ltd.Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading...

» PDE-5 Inhibitors in Scleroderma Raynaud Phenomenon and Digital Ulcers

Systemic sclerosis- (SSc-) related vasculopathy, as manifested by Raynaud’s Phenomenon (RP) and digital ulcers (DUs), is associated with significant impairment of the quality of life and morbidity. The current vasoactive approach for SSc-RP,...

» Raynaud's Syndrome

John W. Hallett, Jr., MDJanuary 2008Raynaud's syndrome is vasospasm of parts of the hand in response to cold or emotional stress, causing reversible discomfort and color changes (pallor, cyanosis, erythema, or a combination) in one or more digits....

» Small Intestinal Bacterial Overgrowth A Problem For Scleroderma Patients

More than a third of patients with systemic sclerosis and intestinal symptoms have an increase in gastrointestinal tract bacteria, an alteration in the type of gut microbes present, or both, based on data from a French study presented at the annual...

» Thank You

The Scleroderma Care Foundation launched its one month ago on September 1st, and we did so with several aims in mind. Firstly we sought to provide patients, their families, and friends with relevant and timely information on Scleroderma, tips for...